Reply: Evaluation of Response to High-Dose Intravenous Vitamin K Administration

Chapman AR Yerke JR Lumpkin M , et al. Evaluation of response to high-dose intravenous vitamin K administration [published online ahead of print February 20, 2023]. Ann Pharmacother. doi:10.1177/106002802311542.

Mladěnka P Macakova K Krcmova L , et al. Vitamin K—sources, physiological role, kinetics, deficiency, detection, therapeutic use, and toxicity. Nutr Rev. 2022;80(4):677-698. doi:10.1093/ nutrit/nuab061

Sultana H Komai M Shirakawa H . The role of vitamin K in cholestatic liver disease. Nutrients. 2021;13:2515. doi:10.3390/nu13082515.

Tripodi A Salerno F Chantarangkul V , et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005;41(3):553-558. doi:10.1002/hep.20569.

O’Leary JG Greenberg CS Patton HM Caldwell SH . AGA clinical practice update: coagulation in cirrhosis. Gastroenterology. 2019;157(1):34-43. doi:10.1053/j.gastro.2019.03.070.

WHO Expert Committee on Biological Standardization (Technical Report Series No. 687, 33rd Report). Geneva, Switzerland: World Health Organization; 1983.

Senzolo M Burra P Cholongitas E , et al. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol. 2006;12(48):7725-7736. doi:10.3748/wjg.v12.i48.7725.

Nanchal R Subramanian R Karvellas CJ , et al. Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU: cardiovascular, endocrine, hematologic, pulmonary and renal considerations: executive summary. Crit Care Med. 2020;48(3):415-419.